These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6095682)

  • 1. Hypothalamic sodium-transport inhibitor is a high-affinity reversible inhibitor of Na+-K+-ATPase.
    Haupert GT; Carilli CT; Cantley LC
    Am J Physiol; 1984 Dec; 247(6 Pt 2):F919-24. PubMed ID: 6095682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
    Myers TD; Boerth RC; Post RL
    Biochim Biophys Acta; 1979 Nov; 558(1):99-107. PubMed ID: 227460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on ouabain-complexed (Na+ +K+)-ATPase carried out with vanadate.
    Hansen O
    Biochim Biophys Acta; 1982 Nov; 692(2):187-95. PubMed ID: 6293562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification with potassium and vanadate of two classes of specific ouabain binding sites in a (Na+ + K+) ATPase preparation from the guinea-pig heart.
    Godfraind T; De Pover A; Lutete DN
    Biochem Pharmacol; 1980 Apr; 29(8):1195-9. PubMed ID: 6248074
    [No Abstract]   [Full Text] [Related]  

  • 5. Facilitation of ouabain binding to (Na+ + K+)-ATPase by vanadate at in vivo concentrations.
    Hansen O
    Biochim Biophys Acta; 1979 May; 568(1):265-9. PubMed ID: 221030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanadate interaction with the Na, K-ATPase. An assay of serum vanadate based on the displacement of (48V) vanadate from Na, K-ATPase.
    Hansen O
    Basic Res Cardiol; 1980; 75(3):455-9. PubMed ID: 6255933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Na+, K+-ATPase by the endogenous sodium transport inhibitor from hypothalamus.
    Haupert GT
    Hypertension; 1987 Nov; 10(5 Pt 2):I61-6. PubMed ID: 2824368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for a hypothalamic Na+,K+-ATPase inhibitor.
    Haber E; Haupert GT
    Hypertension; 1987 Apr; 9(4):315-24. PubMed ID: 2435655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
    Nechay BR; Saunders JP
    J Environ Pathol Toxicol; 1978; 2(2):247-62. PubMed ID: 216760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vanadate on isolated vascular tissue: biochemical and functional investigations.
    Fox AA; Borchard U; Neumann M
    J Cardiovasc Pharmacol; 1983; 5(2):309-16. PubMed ID: 6188908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-affinity Na+ sites on (Na+ +K+)-ATPase modulate inhibition of Na+-ATPase activity by vanadate.
    Bond GH; Hudgins PM
    Biochim Biophys Acta; 1982 May; 687(2):310-4. PubMed ID: 6284222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and cloning of the K+-independent, ouabain-insensitive Na+-ATPase.
    Rocafull MA; Romero FJ; Thomas LE; del Castillo JR
    Biochim Biophys Acta; 2011 Jun; 1808(6):1684-700. PubMed ID: 21334305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF; Chen E; Ray S; Haupert GT
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of a ouabain-like factor from Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.